LCFY vs. VOR
LCFY (Locafy Ltd) and VOR (Vor Biopharma Inc.) are both stocks. LCFY operates in Internet Content & Information (Communication Services), while VOR operates in Biotechnology (Healthcare). Over the past 3 years, LCFY returned -17.58%/yr vs -44.36%/yr for VOR. At a 0.07 correlation, their price movements are largely independent.
Performance
LCFY vs. VOR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LCFY achieves a 36.79% return, which is significantly higher than VOR's 13.53% return.
LCFY
- 1D
- -1.54%
- 1M
- -4.25%
- YTD
- 36.79%
- 6M
- 21.59%
- 1Y
- 42.91%
- 3Y*
- -17.58%
- 5Y*
- —
- 10Y*
- —
VOR
- 1D
- -0.60%
- 1M
- 3.63%
- YTD
- 13.53%
- 6M
- 9.76%
- 1Y
- 156.03%
- 3Y*
- -44.36%
- 5Y*
- -48.26%
- 10Y*
- —
LCFY vs. VOR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
LCFY Locafy Ltd | 36.79% | -59.24% | -24.30% | 53.82% | -91.17% |
VOR Vor Biopharma Inc. | 13.53% | -41.08% | -50.67% | -66.17% | -10.86% |
Correlation
The correlation between LCFY and VOR is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Mar 25, 2022 | 0.07 |
Fundamentals
LCFY:
$6.95M
VOR:
$638.72M
LCFY:
-A$1.44
VOR:
-$53.66
LCFY:
A$3.63M
VOR:
$0.00
LCFY:
A$3.63M
VOR:
-$23.00K
LCFY:
-A$803.06K
VOR:
-$1.13B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LCFY vs. VOR — Risk / Return Rank
LCFY
VOR
LCFY vs. VOR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Locafy Ltd (LCFY) and Vor Biopharma Inc. (VOR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LCFY | VOR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.76 | ||
| Sortino ratioReturn per unit of downside risk | +0.25 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.33 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 0.63 | 1.80 | -1.17 |
| Martin ratioReturn relative to average drawdown | 0.90 | 2.54 | -1.64 |
Loading charts...
Drawdowns
LCFY vs. VOR - Drawdown Comparison
The maximum LCFY drawdown since its inception was -96.59%, roughly equal to the maximum VOR drawdown of -99.72%. Use the drawdown chart below to compare losses from any high point for LCFY and VOR.
Loading charts...
Drawdown Indicators
| LCFY | VOR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.59% | -99.72% | +3.13% |
Max Drawdown (1Y)Largest decline over 1 year | -68.07% | -87.15% | +19.08% |
Max Drawdown (3Y)Largest decline over 3 years | -76.75% | -96.49% | +19.74% |
Max Drawdown (5Y)Largest decline over 5 years | — | -99.29% | — |
Current DrawdownCurrent decline from peak | -94.27% | -98.63% | +4.36% |
Average DrawdownAverage peak-to-trough decline | -88.80% | -88.73% | -0.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.67% | 61.73% | -14.06% |
Volatility
LCFY vs. VOR - Volatility Comparison
The current volatility for Locafy Ltd (LCFY) is 17.97%, while Vor Biopharma Inc. (VOR) has a volatility of 21.30%. This indicates that LCFY experiences smaller price fluctuations and is considered to be less risky than VOR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LCFY | VOR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.97% | 21.30% | -3.33% |
Volatility (6M)Calculated over the trailing 6-month period | 65.56% | 63.03% | +2.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 249.44% | 169.42% | +80.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 174.98% | 116.43% | +58.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 174.98% | 116.53% | +58.45% |
Dividends
LCFY vs. VOR - Dividend Comparison
Neither LCFY nor VOR has paid dividends to shareholders.
Financials
LCFY vs. VOR - Financials Comparison
This section allows you to compare key financial metrics between Locafy Ltd and Vor Biopharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
LCFY and VOR have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VOR has higher volatility (21.30%) compared to LCFY (17.97%). In terms of maximum drawdown, LCFY dropped -96.59% vs VOR's -99.72%.
VOR currently has the higher Sharpe Ratio (0.93 vs 0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LCFY and VOR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer